Meyka AI API is live for developers.Start building.
Advertisement
Avidity Biosciences Inc

Avidity Biosciences Inc (RNAM) Stock Overview

Explore Avidity Biosciences Inc’s financial performance, market position, analyst ratings, and future outlook.

RNAM●NASDAQ
HealthcareBiotechnology
$72.86
$0.04(0.05%)
U.S. Market opens in 51h 50m
Advertisement

Avidity Biosciences Inc (RNAM)

Meyka AI Score

Z

Key Financials

Market Cap11.3B
P/E Ratio-15.89
EPS (TTM)$-4.19
ROE-0.45%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

RNAM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Avidity Biosciences Inc (RNAM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.89 and a market capitalization of 11.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
2.13%
3-Month Change
0.30%
6-Month Change
0.30%
Year-to-Date (YTD) Change
0.30%
1-Year Change
0.30%
3-Year Change
0.30%
5-Year Change
0.30%
All-Time (Max) Change
0.30%

Contact Information

http://www.aviditybiosciences.com
1 858 401 7900
3020 Callan Road, San Diego, CA, 92121

Company Facts

5,110 Employees
IPO DateJun 12, 2020
CountryUS

Frequently Asked Questions